|
Market Closed -
NSE India S.E.
11:05:07 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2,265.70 INR | +1.79% |
|
+3.26% | +11.33% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.6B | |||||
| 1,140B | |||||
| 641B | |||||
| 507B | |||||
| 383B | |||||
| 347B |
Select your edition
All financial news and data tailored to specific country editions
